Mohammad Mehdi Ommati

Prof. Dr. Mohammad Mehdi Ommati

Animal Sciences and Veterinary Medicine, Henan University of Science and Technology, Luoyang, Henan, China
orcid
He serves as an Editorial Board Member and Reviewer of more ...

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RHReza Heidari
Reza Heidari
AAAsrin Ahmadi
Asrin Ahmadi
HMHamidreza Mohammadi
Hamidreza Mohammadi
Mohammad Mehdi OmmatiMohammad Mehdi Ommati
Mohammad Mehdi Ommati
NANegar Azarpira
Negar Azarpira
HNHossein Niknahad
Hossein Niknahad

1 July 2018 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
RHReza Heidari
Reza Heidari
HNHossein Niknahad
Hossein Niknahad
ASAla Sadeghi
Ala Sadeghi
HMHamidreza Mohammadi
Hamidreza Mohammadi
VGVahid Ghanbarinejad
Vahid Ghanbarinejad
AJAkram Jamshidzadeh
Akram Jamshidzadeh

1 February 2017 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Closed access
AJAkram Jamshidzadeh
Akram Jamshidzadeh
RHReza Heidari
Reza Heidari
MAMozhgan Abasvali
Mozhgan Abasvali
MZMehdi Zarei
Mehdi Zarei
Mohammad Mehdi OmmatiMohammad Mehdi Ommati
Mohammad Mehdi Ommati
ANAsma Najibi
Asma Najibi

1 January 2019 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
RHReza Heidari
Reza Heidari
SBShima Behnamrad
Shima Behnamrad
ZKZahra Khodami
Zahra Khodami
Mohammad Mehdi OmmatiMohammad Mehdi Ommati
Mohammad Mehdi Ommati
NANegar Azarpira
Negar Azarpira
AVAfsaneh Vazin
Afsaneh Vazin
Colistin (COL) belongs to the polymixin class of antibiotics used as the last line antibiotic against drug-resistant infections. However, nephrotoxicity is the major deleterious and dose-limiting side effect associated with COL therapy. Oxidative stress and mitochondrial impairment are suspected mechanisms involved in COL-induced nephrotoxicity. Taurine is one of the most abundant amino acids in the human body with antioxidant and mitochondria protecting properties. The current study was designed to evaluate the potential nephroprotective properties of taurine against COL-associated nephrotoxicity. Mice were treated with COL (15 mg/kg/day, i.v, for 7 consecutive days) alone or in combination with taurine (500 and 1000 mg/kg, i.p). Plasma biomarkers of nephrotoxicity in addition of kidney tissue markers of oxidative stress were evaluated. Additionally, kidney mitochondria were isolated, and several mitochondrial indices were assessed. The COL-associated renal injury was evident by a significant increase in plasma markers of renal injury including creatinine (Cr), and blood urine nitrogen (BUN). COL treatment also caused a significant increase in kidney reactive oxygen species (ROS) and lipid peroxidation (LPO). Renal GSH reservoirs and antioxidant capacity were also decreased in COL-treated animals. Mitochondrial parameters including mitochondrial dehydrogenase activity, membrane potential, GSH, and ATP were significantly decreased while mitochondrial LPO, permeabilization, and GSSG content were increased in the kidney of COL-treated mice. It was found that taurine (500 and 1000 mg/kg, i.p) treatment alleviated COL-induced oxidative stress and mitochondrial dysfunction in the kidney tissue. The data obtained from the current study suggest mitochondrial dysfunction and oxidative stress as fundamental mechanisms of renal injury induced by COL. On the other hand, taurine supplementation protected kidney through decreasing oxidative stress and regulating mitochondrial function.

17 September 2018 in Archives of Toxicology
Verified
Journal Article
Closed access
PDF file
RMRam Kumar Manthari
Ram Kumar Manthari
CTChiranjeevi Tikka
Chiranjeevi Tikka
Mohammad Mehdi OmmatiMohammad Mehdi Ommati
Mohammad Mehdi Ommati
RNRuiyan Niu
Ruiyan Niu
ZSZilong Sun
Zilong Sun
JWJundong Wang
Jundong Wang

1 January 2016 in Toxicology Reports
Verified
Journal Article
Open access
RHReza Heidari
Reza Heidari
AJAkram Jamshidzadeh
Akram Jamshidzadeh
HNHossein Niknahad
Hossein Niknahad
EMElnaz Mardani
Elnaz Mardani
Mohammad Mehdi OmmatiMohammad Mehdi Ommati
Mohammad Mehdi Ommati
ANAsma Najibi
Asma Najibi
Hyperammonemia is associated with chronic and acute liver injury. There is no promising therapeutic agent against ammonia-induced complications. Hence, finding therapeutic molecules with safe profile of administration has clinical value. The present study was conducted to evaluate the role of taurine (TA) administration on plasma and brain ammonia and its consequent events in different models of chronic and acute liver injury and hyperammonemia. Bile duct ligated (BDL) rats were used as a model of chronic liver injury. Thioacetamide and acetaminophen-induced acute liver failure were used as acute liver injury models. A high level of ammonia was detected in blood and brain of experimental groups. An increase in brain ammonia level coincided with a decreased total locomotor activity of animals and significant changes in the biochemistry of blood and also liver tissue. TA administration (500 and 1000 mg/kg, i.p), effectively alleviated liver injury and its consequent events including rise in plasma and brain ammonia and brain edema. The data suggested that TA is not only a useful and safe agent to preserve liver function, but also prevented hyperammonemia as a deleterious consequence of acute and chronic liver injury.